Detection and characterization of circulating tumor cells in lung cancer: Why and how?

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

(2015) E. Pailler et al.   ANNALS OF ONCOLOGY

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

(2015) Francesca Fenizia et al.   Future Oncology

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

(2015) Scott N. Gettinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings

(2015) Christy E. Cauley et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

miR-Test: A Blood Test for Lung Cancer Early Detection

(2015) Francesca Montani et al.   JNCI-Journal of the National Cancer Institute

miR-Test: A Blood Test for Lung Cancer Early Detection

(2015) Francesca Montani et al.   JNCI-Journal of the National Cancer Institute

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

(2014) M. Ignatiadis et al.   ANNALS OF ONCOLOGY

European cancer mortality predictions for the year 2014

(2014) M. Malvezzi et al.   ANNALS OF ONCOLOGY

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) M. Reck et al.   ANNALS OF ONCOLOGY

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer

(2014) M Ilie et al.   BRITISH JOURNAL OF CANCER

Detection of Circulating Tumor Cells from Lung Cancer Patients in the Era of Targeted Therapy : Promises, Drawbacks and Pitfalls

(2014) V. Hofman et al.   CURRENT MOLECULAR MEDICINE

Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology

(2014) Emanuel Stutz et al.   Future Oncology

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

(2014) Maxim B. Freidin et al.   LUNG CANCER

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

(2014) Cassandra L Hodgkinson et al.   NATURE MEDICINE

Molecular analysis of circulating tumour cells—biology and biomarkers

(2014) Matthew G. Krebs et al.   Nature Reviews Clinical Oncology

MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis

(2014) Wenjie Zhu et al.   PLoS One

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

(2014) Marius Ilie et al.   PLoS One

Circulating tumor cells: utopia or reality?

(2013) Vincenza Conteduca et al.   Future Oncology

Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer

(2013) Emma Pailler et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

(2013) Chee Khoon Lee et al.   JNCI-Journal of the National Cancer Institute

microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer

(2013) Riccardo Cazzoli et al.   Journal of Thoracic Oncology

Technologies for detection of circulating tumor cells: facts and vision

(2013) Catherine Alix-Panabières et al.   LAB ON A CHIP

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

(2013) Bing Li et al.   LUNG CANCER

Tracking tumor resistance using 'liquid biopsies'

(2013)   NATURE MEDICINE

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC

(2013) Céline Sanfiorenzo et al.   PLoS One

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma

(2012) M. Ilie et al.   ANNALS OF ONCOLOGY

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

(2012) Jian-Mei Hou et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer

(2011) Jian-Mei Hou et al.   AMERICAN JOURNAL OF PATHOLOGY

Circulating Epithelial Cells in Patients with Benign Colon Diseases

(2011) K. Pantel et al.   CLINICAL CHEMISTRY

Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

(2011) V. Hofman et al.   CYTOPATHOLOGY

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

(2011) Matthew G. Krebs et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

(2011) Alice T Shaw et al.   LANCET ONCOLOGY

Cytopathologic Detection of Circulating Tumor Cells Using the Isolation by Size of Epithelial Tumor Cell Method

(2010) Véronique J. Hofman et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

(2010) V. Hofman et al.   CLINICAL CANCER RESEARCH

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

(2010) Véronique Hofman et al.   INTERNATIONAL JOURNAL OF CANCER